Drug Pipeline

Ritlecitinib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
13
Active Studies
6
Recruiting
3
Phase 3
5
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-21 NCT07152626
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for…
Recruitment opened
2026-05-21 NCT07152626
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for…
Trial sites expanded: 1 -> 5 locations
2026-05-15 NCT07226531
Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA…
overall status: "Recruiting" → "Active Not Recruiting"
Active Studies by Phase
Phase 3
3
Phase 2
5
Phase 1
1
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06072183 A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo… Stable Nonsegmental Vitiligo Active, Not Recruiting
NCT06163326 A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants… Vitiligo Active, Not Recruiting
NCT06873945 A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia… Alopecia Areata Active, Not Recruiting
Phase 2
NCT05759468 NAD Augmentation in Diabetes Kidney Disease Type2diabetes Recruiting
NCT07219615 A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous… Chronic Spontaneous Urticaria Recruiting
NCT07228390 A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long… Hidradenitis Suppurativa Recruiting
NCT07152626 Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for… Vitiligo Recruiting
NCT05743244 Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1… Diabetes Mellitus, Type 1 Active, Not Recruiting
Phase 1
NCT07314541 A Phase Ia Study of KMY Tablets in Healthy Subjects Healthy Volunteers Not Yet Recruiting
Not specified
NCT07152119 A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine… Severe Alopecia Areata Recruiting
NCT06531109 Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib Alopecia Areata Recruiting
NCT06279221 Litfulo Capsules Special Investigation Alopecia Areata Active, Not Recruiting
NCT07226531 Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA… Alopecia Areata Active, Not Recruiting
Sponsors Running Ritlecitinib Trials
Disease Areas
Get alerts when Ritlecitinib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free